Tag

Aging – longevity

Exercise

#176 – AMA #27: The importance of muscle mass, strength, and cardiorespiratory fitness for longevity

“If you have the aspiration of kicking ass when you’re 85, you can’t afford to be average when you’re 50.” —Peter Attia

Aging

#175 – Matt Kaeberlein, Ph.D.: The biology of aging, rapamycin, and other interventions that target the aging process

“I don’t think I will ever understand aging fully. And I don’t think the field will. … But I also believe that we don’t have to understand it fully to be able to have an impact on the biology of aging through interventions.” —Matt Kaeberlein

Aging

#171 – Steve Austad, Ph.D.: The landscape of longevity science: making sense of caloric restriction, biomarkers of aging, and possible geroprotective molecules

“I never thought [extending the human lifespan] was going to happen because we got better at treating cancer or we got better at preventing heart disease. I always thought it was going to happen because we would develop something … that would fundamentally change the rate of aging. And we haven’t developed that yet. We’ve got a lot of clues and I think we’re getting closer and closer and closer.” —Steve Austad

Aging

How long can we live?; suggested listening

Revisiting the podcast archive 

Weekly Emails

Protecting against hearing loss

Considerations to protect the ability to hear across a lifespan

COVID-19

Metformin and COVID-19 mortality risk; a timeline of Kobe’s last day

A few things worth checking out: 03-28-2021

Treatments

#148 – Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the Interventions Testing Program

“I don’t really care what causes aging. What I care about is: What is the process that can postpone all the different aspects of aging?” — Rich Miller

Diseases

#134 – James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise

If exercise were a drug, it would be the best drug we have for preventing heart disease . . .. But like with any drug, you’ve got to get the dose right.” — James O’Keefe

Aging

#123 – Joan Mannick, M.D. & Nir Barzilai, M.D.: Rapamycin and metformin—longevity, immune enhancement, and COVID-19

“I think what the mTOR inhibitors are doing is not stopping people from getting infected [with a virus], but if you get infected, there’s a better immune response and your symptoms will be milder.” — Joan Mannick

Facebook icon Twitter icon Instagram icon Pinterest icon Google+ icon YouTube icon LinkedIn icon Contact icon